The UK is witnessing a growing surge in interest surrounding entheogenic substances. Beyond the familiar use of psilocybin and LSD, researchers and enthusiasts are increasingly exploring less-charted territories, particularly copyright and the relatively new cannabinoid, CBG compound. The evolvin